Anderson Danyon J, Vazirnia Parsia, Loehr Catherine, Sternfels Whitney, Hasoon Jamal, Viswanath Omar, Kaye Alan D, Urits Ivan
School of Medicine, Medical College of Wisconsin.
School of Medicine, Louisiana State University Health Sciences Center.
Health Psychol Res. 2022 Nov 26;10(4):38956. doi: 10.52965/001c.38956. eCollection 2022.
Depression is a common disorder that affects millions globally and is linked to reduced quality of life and mortality. Its pathophysiology is complex and there are several forms of treatment proposed in the literature with differing side effect profiles. Many patients do not respond to treatment which warrants augmentation with other treatments and the investigation of novel treatments. One of these treatments includes testosterone therapy which evidence suggests might improve depressed mood in older patients with low levels of testosterone and helps restore physical impairments caused by age-related hormonal changes.
The objective of this review is to synthesize information regarding clinical depression, its treatment options, and the efficacy and safety of testosterone treatment for the treatment of depression.
This review utilized comprehensive secondary and tertiary data analysis across many academic databases and published work pertaining to the topic of interest.
Within some subpopulations such as men with dysthymic disorder, treatment resistant depression, or low testosterone levels, testosterone administration yielded positive results in the treatment of depression. Additionally, rodent models have shown that administering testosterone to gonadectomized male animals reduces symptoms of depression. Conversely, some studies have found no difference in depressive symptoms after treatment with testosterone when compared with placebo. It was also noted that over administration of testosterone is associated with multiple adverse effects and complications.
The current evidence provides mixed conclusions on the effectiveness of testosterone therapy for treating depression. More research is needed in adult men to see if declining testosterone levels directly influence the development of depression.
抑郁症是一种常见疾病,全球数以百万计的人受其影响,它与生活质量下降和死亡率相关。其病理生理学复杂,文献中提出了几种治疗方法,副作用各不相同。许多患者对治疗无反应,这就需要用其他治疗方法加强治疗并研究新的治疗方法。其中一种治疗方法包括睾酮治疗,有证据表明,睾酮治疗可能改善睾酮水平低的老年患者的抑郁情绪,并有助于恢复因年龄相关激素变化引起的身体损伤。
本综述的目的是综合有关临床抑郁症、其治疗选择以及睾酮治疗抑郁症的疗效和安全性的信息。
本综述利用了多个学术数据库的综合二级和三级数据分析以及与感兴趣主题相关的已发表文献。
在一些亚人群中,如患有心境恶劣障碍、难治性抑郁症或睾酮水平低的男性,睾酮给药在抑郁症治疗中产生了积极结果。此外,啮齿动物模型表明,对去势雄性动物给予睾酮可减轻抑郁症状。相反,一些研究发现,与安慰剂相比,睾酮治疗后抑郁症状没有差异。还指出,过量使用睾酮会导致多种不良反应和并发症。
目前的证据对于睾酮治疗抑郁症的有效性得出了不一致的结论。成年男性需要更多研究,以确定睾酮水平下降是否直接影响抑郁症的发展。